In the days of the Armada, a fleet of warships, the scuttlebutt was the rumor or gossip that would spread throughout the ship. Today, Armada Law Corp presents The Scuttlebutt, a daily summery of news articles that people within the cannabis, hemp and plant medicine industries are chatting about along with links to the full articles.
In today’s news:
#californiacannabis – “The changes would tax outdoor cultivators $. 75 per square foot, indoor cultivators $12.50 per square foot and mixed-light cultivators $3 per square foot.That would mean a decrease for outdoor growers and an increase for indoor cultivators, Roeser said. Small mixed-light operators, which use a combination of natural and artificial lighting, would likely see an increase while large mixed-light operators would see a decrease, Roeser said.”
#californiacannabis – “Under Assembly Bill 935, current smokers would be able to continue buying tobacco products, but anyone younger than 16 years old today would not be able to buy tobacco—ever….
The ban, however, would not apply to cannabis sales. Lawmakers reasoned that the compulsive nature of nicotine compels youth to become addicted.”
#cannabisindustry – “Truck drivers are another group that must be hyperaware of what products they ingest. The Department of Transportation’s Drug and Alcohol Testing Regulation does not authorize “medical marijuana” under a state law to be a valid medical explanation for a transportation employee’s positive drug test result.
The DOT regulation specifies, “You must not verify a test negative based on information that a physician recommended that the employee use a drug listed in Schedule I of the Controlled Substances Act. (i.e. under a state law that purports to authorize such a recommendation, such as the ‘medical marijuana’ laws that some states have adopted.)”
Therefore, medical review officers will not verify a drug test as negative based upon information that a physician recommended that the employee use “medical marijuana.””
#psilocybin – “The passage of Proposition 122 in November marked a long, strange trip for Colorado. But it appears that trip has just begun, stumbling out of the gate.
The regulators responsible for setting the rules governing psilocybin use have told the Legislature they have little to no clue how to do that. There is no timeline for the state Senate to approve Gov. Jared Polis’ 15-member Natural Medicine Advisory Board, which includes Aspen City Councilman Skippy Mesirow.
That’s just the start of the hurdles to Colorado’s work to build a legal industry in the coming years around psychedelics as medicine.”
#psychedelics – “The key to treating intractable mental health disorders could be regrowing shrunken brain cells.
“Growth is good” when it comes to treating neuropsychiatric diseases, says David Olson, founding director of the Institute for Psychedelics and Neurotherapeutics at the University of California, Davis.
That’s because those brain cells, prefrontal cortex neurons, tend to be atrophied, with branches retracted and synapses pruned back, in the brains of people with conditions like depression, PTSD and substance-use disorder, Olson told Erin.”
#cannabisindustry – “A Missouri appellate court said on Tuesday that the state’s cannabis regulator failed to adhere to its own rules when it rejected a company’s application to open a medical marijuana cultivation facility.
The 2-1 majority said that the Department of Health and Senior Services neglected to inform applicant MO Cann Do Inc. that its initial application lacked a certificate of good standing as a corporation and that it therefore could not reject the company’s subsequent applications.
“We agree that the Commission’s decision was unauthorized by law in that the DHSS failed to follow … its own regulation, when it failed to specify in the deficiency letter that [MO Cann Do’s] application was incomplete for lack of a certificate of good standing,” Judge James M. Dowd wrote for the majority.”